Genotype–phenotype correlations in Down syndrome identified by array CGH in 30 cases of partial trisomy and partial monosomy chromosome 21

[1]  J M Delabar,et al.  Classification of human chromosome 21 gene-expression variations in Down syndrome: impact on disease phenotypes. , 2007, American journal of human genetics.

[2]  M. Delorenzi,et al.  Natural gene-expression variation in Down syndrome modulates the outcome of gene-dosage imbalance. , 2007, American journal of human genetics.

[3]  M. Pletnikov,et al.  Trisomy for the Down syndrome 'critical region' is necessary but not sufficient for brain phenotypes of trisomic mice. , 2007, Human molecular genetics.

[4]  J. Delabar,et al.  Developmental Defects in Trisomy 21 and Mouse Models , 2006, TheScientificWorldJournal.

[5]  S. Mizuno,et al.  Two cases of partial trisomy 21 (pter‐q22.1) without the major features of Down syndrome , 2006, American journal of medical genetics. Part A.

[6]  Ingrid K. Glad,et al.  CGH-Explorer: a program for analysis of array-CGH data , 2005, Bioinform..

[7]  J. Horst,et al.  Mild phenotype in two unrelated patients with a partial deletion of 21q22.2‐q22.3 defined by FISH and molecular studies , 2004, American journal of medical genetics. Part A.

[8]  Stylianos E. Antonarakis,et al.  Chromosome 21 and Down syndrome: from genomics to pathophysiology , 2004, Nature Reviews Genetics.

[9]  Kenny Q. Ye,et al.  Large-Scale Copy Number Polymorphism in the Human Genome , 2004, Science.

[10]  S. South,et al.  Transcript level alterations reflect gene dosage effects across multiple tissues in a mouse model of down syndrome. , 2004, Genome research.

[11]  S. Antonarakis,et al.  Gene expression from the aneuploid chromosome in a trisomy mouse model of down syndrome. , 2004, Genome research.

[12]  M Bobrow,et al.  Microarray based comparative genomic hybridisation (array-CGH) detects submicroscopic chromosomal deletions and duplications in patients with learning disability/mental retardation and dysmorphic features , 2004, Journal of Medical Genetics.

[13]  R. Reeves,et al.  Global disruption of the cerebellar transcriptome in a Down syndrome mouse model. , 2003, Human molecular genetics.

[14]  James M. Eldred,et al.  The DNA sequence of human chromosome 7 , 2003, Nature.

[15]  Jonathan Pevsner,et al.  Global up-regulation of chromosome 21 gene expression in the developing Down syndrome brain. , 2003, Genomics.

[16]  N. Carter,et al.  DNA microarrays for comparative genomic hybridization based on DOP‐PCR amplification of BAC and PAC clones , 2003, Genes, chromosomes & cancer.

[17]  L. Nadel,et al.  The neuropsychology of Down syndrome: evidence for hippocampal dysfunction. , 2003, Child development.

[18]  N. Hastie,et al.  Transcriptome analysis of human autosomal trisomy. , 2002, Human molecular genetics.

[19]  W. J. Kent,et al.  BLAT--the BLAST-like alignment tool. , 2002, Genome research.

[20]  E. Zackai,et al.  Down syndrome congenital heart disease: A narrowed region and a candidate gene , 2001, Genetics in Medicine.

[21]  X. Estivill,et al.  The mouse brain transcriptome by SAGE: differences in gene expression between P30 brains of the partial trisomy 16 mouse model of Down syndrome (Ts65Dn) and normals. , 2000, Genome research.

[22]  Shinsei Minoshima,et al.  Erratum: The DNA sequence of human chromosome 21: The chromosome 21 mapping and sequencing consortium (Nature (2000) 405 (311-319)) , 2000 .

[23]  M. Hattori,et al.  The DNA sequence of human chromosome 21 , 2000, Nature.

[24]  G. Marfany,et al.  Molecular characterisation of partial chromosome 21 aneuploidies by fluorescent PCR , 1999, Journal of medical genetics.

[25]  C. Torfs,et al.  Anomalies in Down syndrome individuals in a large population-based registry. , 1998, American journal of medical genetics.

[26]  C. Epstein,et al.  Ts1Cje, a partial trisomy 16 mouse model for Down syndrome, exhibits learning and behavioral abnormalities. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[27]  A. Mégarbané,et al.  High-resolution physical mapping of a 6.7-Mb YAC contig spanning a region critical for the monosomy 21 phenotype in 21q21.3-q22.1. , 1997, Genomics.

[28]  B. Birren,et al.  Construction and characterization of a human bacterial artificial chromosome library. , 1996, Genomics.

[29]  J. Tolmie,et al.  Down syndrome with partial duplication and del (21) syndrome: study protocol and call for collaboration. Study I: clinical assessment , 1996, Clinical genetics.

[30]  C. Cole,et al.  Physical findings in 21q22 deletion suggest critical region for 21q- phenotype in q22. , 1995, American journal of medical genetics.

[31]  R. Bronson,et al.  A mouse model for Down syndrome exhibits learning and behaviour deficits , 1995, Nature Genetics.

[32]  J. Huret,et al.  Monosomy 21q: two cases of del(21q) and review of the literature , 1995, Clinical genetics.

[33]  B. Delobel,et al.  Molecular mapping of 21 features associated with partial monosomy 21: involvement of the APP-SOD1 region. , 1995, American journal of human genetics.

[34]  S. Antonarakis,et al.  "Compensatory" uniparental disomy of chromosome 21 in two cases. , 1994, Journal of medical genetics.

[35]  C. Disteche,et al.  Down syndrome phenotypes: the consequences of chromosomal imbalance. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[36]  C. Disteche,et al.  Down syndrome: molecular mapping of the congenital heart disease and duodenal stenosis. , 1992, American journal of human genetics.

[37]  F. Apiou,et al.  Cytogenetic and molecular analysis of a de novo tandem duplication of chromosome 21 , 1991, Human Genetics.

[38]  B. Craig,et al.  CONGENITAL HEART DISEASE IN DOWNʼS SYNDROME: TWO-YEAR PROSPECTIVE EARLY SCREENING STUDY , 1991 .

[39]  E. Courchesne,et al.  Protocols to establish genotype-phenotype correlations in Down syndrome. , 1991, American journal of human genetics.

[40]  D. Cox,et al.  Deletion of chromosome 21 and normal intelligence: molecular definition of the lesion , 1991, Human Genetics.

[41]  S. Pulst,et al.  Molecular definition of a region of chromosome 21 that causes features of the Down syndrome phenotype. , 1990, American journal of human genetics.

[42]  A. Aurias,et al.  Critical role of the D21S55 region on chromosome 21 in the pathogenesis of Down syndrome. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[43]  L. Tranebjaerg,et al.  A case of partial monosomy 21q22.2 associated with Rieger's syndrome. , 1984, Journal of medical genetics.

[44]  Yoshifumi Yamamoto,et al.  A case of 21q-syndrome with normal SOD-1 activity , 1979, Human Genetics.

[45]  B. Dutrillaux,et al.  [Partial trisomy of chromosome 21 by maternal translocation t(15;21) (q26.2; q21)]. , 1976, Annales de genetique.

[46]  J. Jackson,et al.  Clinical diagnosis of Down's syndrome , 1976, Clinical genetics.

[47]  M. Mikkelsen,et al.  Karyotype 45,XX,−21/46,XX,21q− in an infant with symptoms of G-deletion syndrome I , 1974, Journal of medical genetics.

[48]  B. Dutrillaux,et al.  [Translocation 46,XX, t(15; 21) (q13; q22,1) in the mother of 2 children with partial trisomy 15 and monosomy 21]. , 1973, Annales de genetique.

[49]  J. Delabar,et al.  Mapping of the Down syndrome phenotype on chromosome 21 at the molecular level. , 1994, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[50]  J. Delabar,et al.  Molecular Mapping of Twenty-Four Features of Down Syndrome on Chromosome 21 , 1993, European journal of human genetics : EJHG.

[51]  M. K. McCormick.  Molecular genetic approach to the characterization of the ‘Down syndrome region’ of chromosome 21 , 1989 .

[52]  J. McPherson,et al.  A Chromosome 21 Critical Region Does Not Cause Specific Down Syndrome Phenotypes , 2022 .